Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr943 Inhibitors

Olr943 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the olfactory receptor 943 (Olr943). Olfactory receptors are a large family of G-protein-coupled receptors (GPCRs) involved in the detection of odor molecules, and Olr943 is one such receptor encoded by the Olr943 gene. These inhibitors function by binding to the active site or an allosteric site of the receptor, thereby preventing its activation by natural ligands. This inhibition can be highly selective, depending on the structure of the inhibitor and its affinity for Olr943, and it may involve a variety of chemical interactions such as hydrogen bonding, hydrophobic interactions, and van der Waals forces.

The design and synthesis of Olr943 inhibitors often involve structure-activity relationship (SAR) studies to optimize their binding affinity and specificity. These studies typically include the modification of chemical groups within the inhibitor molecule to enhance its interaction with Olr943, as well as the use of computational modeling to predict and analyze binding modes. Additionally, high-throughput screening methods may be employed to identify promising candidates from large libraries of chemical compounds. Once potential inhibitors are identified, further refinement and testing are conducted to ensure that they exhibit the desired properties, such as high potency and minimal off-target effects. Overall, the development of Olr943 inhibitors represents a sophisticated process that combines elements of organic chemistry, biochemistry, and molecular biology to achieve precise modulation of olfactory receptor activity.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Targets BCR-ABL and other tyrosine kinases, possibly affecting signaling pathways interacting with Olr943.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Targets RAF kinase, VEGFR, and PDGFR, potentially affecting various signaling cascades related to Olr943.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

Selectively inhibits BCR-ABL, possibly influencing signaling pathways that intersect with Olr943.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Inhibits VEGFR, PDGFR, and c-Kit, which could indirectly modulate signaling pathways related to Olr943.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

EGFR tyrosine kinase inhibitor, could impact signaling pathways associated with Olr943.

Afatinib

439081-18-2sc-364398
sc-364398A
5 mg
10 mg
$114.00
$198.00
13
(2)

Irreversible EGFR inhibitor, may alter signaling cascades that interact with Olr943.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Inhibits Bruton's tyrosine kinase, potentially influencing pathways related to Olr943 activity.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

EGFR inhibitor, might affect cellular signaling pathways associated with Olr943.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

MEK inhibitor, could indirectly affect signaling relevant to Olr943's function.

Lenvatinib

417716-92-8sc-488530
sc-488530A
sc-488530B
5 mg
25 mg
100 mg
$182.00
$661.00
$1690.00
3
(0)

Inhibits multiple tyrosine kinases, potentially impacting various pathways affecting Olr943.